MOODY ALDRICH PARTNERS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
MOODY ALDRICH PARTNERS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$1,901,000
-5.5%
16,651
+4.1%
0.49%
-14.0%
Q1 2019$2,011,000
-36.8%
15,994
-31.8%
0.56%
-45.9%
Q4 2018$3,182,000
-44.5%
23,446
+12.3%
1.04%
-36.7%
Q3 2018$5,729,000
+4.6%
20,871
-21.0%
1.65%
-15.2%
Q2 2018$5,476,00026,4321.95%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders